Journey Medical Corporation Common Stock
DERM US48115J1097
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Alloush Ramsey COO |
6.84 USD |
2,857 Sold |
19,542 USD |
02/05/2025 | 02/05/2025 |
Maraoui Claude CEO |
6.84 USD |
4,834 Sold |
33,065 USD |
02/05/2025 | 02/05/2025 |
Maraoui Claude CEO |
6.84 USD |
4,834 Sold |
33,065 USD |
02/05/2025 | 02/05/2025 |
Alloush Ramsey COO |
6.84 USD |
2,857 Sold |
19,542 USD |
02/05/2025 | 02/05/2025 |
Benesch Joseph CFO |
6.84 USD |
2,409 Sold |
16,478 USD |
02/05/2025 | 02/05/2025 |
Benesch Joseph CFO |
6.84 USD |
2,409 Sold |
16,478 USD |
02/05/2025 | 02/05/2025 |
Maraoui Claude CEO |
5.01 USD |
49,271 Sold |
246,848 USD |
11/03/2025 | 11/03/2025 |
Maraoui Claude CEO |
5.01 USD |
14,905 Sold |
74,674 USD |
06/03/2025 | 07/03/2025 |
Maraoui Claude CEO |
5.04 USD |
25,551 Sold |
128,777 USD |
06/03/2025 | 06/03/2025 |
Maraoui Claude CEO |
5.13 USD |
18,147 Sold |
93,094 USD |
03/03/2025 | 05/03/2025 |